2011 annual financial data
BioMarin Pharmaceutical 2011 Operating margin
Direct answer
Operating margin was -7.68%.
Operating income was -33,890,000 USD and net income was -53,836,000 USD.
Operating cash flow was 18,753,000 USD.
Get free BioMarin Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 441,358,000 USD
- Operating income
- -33,890,000 USD
- Net income
- -53,836,000 USD
- Operating cash flow
- 18,753,000 USD